TECHNOLOGY

Advanced Biologics was initially formed in 2009 when it introduced the innovative OsteoAMP® product line to the orthopaedic and neurosurgery markets.  OsteoAMP was divested in 2014 to Bioventus

 

Subsequent technology introductions include a cellular bone matrix, OsseoGEN®, and an allograft derived growth factor, ProteiOS®.  Both currently being distributed by Biologica Technologies.

OsseoGEN Logo_4C.jpg

OsseoGEN is Advanced Biologics' cell based allograft matrix distributed by Biologica Technologies.  For additional information, click on this link.

Cap Off[2].jpg
ProteiOS_logo_RGB.21-removebg.png

ProteiOS is Advanced Biologics' allograft derived growth factor distributed by Biologica Technologies.  For additional information, click on this link.

BT_ProteiOS_PromoShot_v1_draft_no GF.png